Search

everythinglearnresearchcommunity

for

Search:↓

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Birth control pills can help reduce mild to moderate acne in women.

Oral contraceptives may cause hair loss in women.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Timing of light therapy affects horse coat growth, with photoperiod being crucial.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Young women with PCOS without additional risk factors may have normal heart function.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.